Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system

Progress in Neurobiology

Volumn 105, Issue , 2013, Pages 60-78

  Verslegers, Mieke ^a   Lemmens, Kim ^a   Van Hove, Inge ^a   Moons, Lieve ^a  

^a SKELETAL BIOLOGY AND ENGINEERING RESEARCH CENTER   (Belgium)

Author keywords

Development; Matrix metalloproteinase 2; Matrix metalloproteinase 9; Nervous system; Plasticity; Repair

Indexed keywords

GELATINASE A; GELATINASE B;

ANGIOGENESIS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INDUCTION; HUMAN; NERVE CELL PLASTICITY; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INJURY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; NEURONAL PLASTICITY; NEURONS;

EID: 84878109046     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2013.03.004     Document Type: Review

References (230)

1. Adair J.C., Charlie J., Dencoff J.E., Kaye J.A., Quinn J.F., Camicioli R.M., Stetler-Stevenson W.G., Rosenberg G.A. Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease. Stroke 2004, 35:e159-e162.
2. Agapova O.A., Ricard C.S., Salvador-Silva M., Hernandez M.R. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes. Glia 2001, 33:205-216.
3. Ahmed Z., Dent R.G., Leadbeater W.E., Smith C., Berry M., Logan A. Matrix metalloproteases: degradation of the inhibitory environment of the transected optic nerve and the scar by regenerating axons. Molecular and Cellular Neurosciences 2005, 28:64-78.
4. Akil M., Pierri J.N., Whitehead R.E., Edgar C.L., Mohila C., Sampson A.R., Lewis D.A. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. American Journal of Psychiatry 1999, 156:1580-1589.
5. Amberger V.R., Avellana-Adalid V., Hensel T., Baron-van Evercooren A., Schwab M.E. Oligodendrocyte-type 2 astrocyte progenitors use a metalloendoprotease to spread and migrate on CNS myelin. European Journal of Neuroscience 1997, 9:151-162.
6. Anelli T., Mannello F., Salani M., Tonti G.A., Poiana G., Biagioni S. Acetylcholine induces neurite outgrowth and modulates matrix metalloproteinase 2 and 9. Biochemical and Biophysical Research Communications 2007, 362:269-274.
7. Arimura N., Menager C., Kawano Y., Yoshimura T., Kawabata S., Hattori A., Fukata Y., Amano M., Goshima Y., Inagaki M., Morone N., Usukura J., Kaibuchi K. Phosphorylation by Rho kinase regulates CRMP-2 activity in growth cones. Molecular and Cellular Biology 2005, 25:9973-9984.
8. Asahina M., Yoshiyama Y., Hattori T. Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain. Clinical Neuropathology 2001, 20:60-63.
9. Avolio C., Ruggieri M., Giuliani F., Liuzzi G.M., Leante R., Riccio P., Livrea P., Trojano M. Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes. Journal of Neuroimmunology 2003, 136:46-53.
10. Ayoub A.E., Cai T.Q., Kaplan R.A., Luo J. Developmental expression of matrix metalloproteinases 2 and 9 and their potential role in the histogenesis of the cerebellar cortex. Journal of Comparative Neurology 2005, 481:403-415.
11. Backstrom J.R., Lim G.P., Cullen M.J., Tokes Z.A. Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40). Journal of Neuroscience 1996, 16:7910-7919.
12. Backstrom J.R., Miller C.A., Tokes Z.A. Characterization of neutral proteinases from Alzheimer-affected and control brain specimens: identification of calcium-dependent metalloproteinases from the hippocampus. Journal of Neurochemistry 1992, 58:983-992.
13. Bajor M., Michaluk P., Gulyassy P., Kekesi A.K., Juhasz G., Kaczmarek L. Synaptic cell adhesion molecule-2 and collapsin response mediator protein-2 are novel members of the matrix metalloproteinase-9 degradome. Journal of Neurochemistry 2012.
14. Barkho B.Z., Munoz A.E., Li X., Li L., Cunningham L.A., Zhao X. Endogenous matrix metalloproteinase (MMP)-3 and MMP-9 promote the differentiation and migration of adult neural progenitor cells in response to chemokines. Stem Cells 2008, 26:3139-3149.
15. Barres B.A., Schmid R., Sendnter M., Raff M.C. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 1993, 118:283-295.
16. Bastos E.F., Marcelino J.L., Amaral A.R., Serfaty C.A. Fluoxetine-induced plasticity in the rodent visual system. Brain Research 1999, 824:28-35.
17. Bednarek N., Clement Y., Lelievre V., Olivier P., Loron G., Garnotel R., Gressens P. Ontogeny of MMPs and TIMPs in the murine neocortex. Pediatric Research 2009, 65:296-300.
18. Bergers G., Brekken R., McMahon G., Vu T.H., Itoh T., Tamaki K., Tanzawa K., Thorpe P., Itohara S., Werb Z., Hanahan D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biology 2000, 2:737-744.
19. Bernardo M.M., Fridman R. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP. Biochemical Journal 2003, 374:739-745.
20. Biederer T., Sara Y., Mozhayeva M., Atasoy D., Liu X., Kavalali E.T., Sudhof T.C. SynCAM, a synaptic adhesion molecule that drives synapse assembly. Science 2002, 297:1525-1531.
21. Bozdagi O., Nagy V., Kwei K.T., Huntley G.W. In vivo roles for matrix metalloproteinase-9 in mature hippocampal synaptic physiology and plasticity. Journal of Neurophysiology 2007, 98:334-344.
22. Brittain J.M., Piekarz A.D., Wang Y., Kondo T., Cummins T.R., Khanna R. An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels. Journal of Biological Chemistry 2009, 284:31375-31390.
23. Butler G.S., Overall C.M. Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics. Biochemistry 2009, 48:10830-10845.
24. Campana W.M., Li X., Dragojlovic N., Janes J., Gaultier A., Gonias S.L. The low-density lipoprotein receptor-related protein is a pro-survival receptor in Schwann cells: possible implications in peripheral nerve injury. Journal of Neuroscience 2006, 26:11197-11207.
25. Canete Soler R., Gui Y.H., Linask K.K., Muschel R.J. MMP-9 (gelatinase B) mRNA is expressed during mouse neurogenesis and may be associated with vascularization. Brain Research. Developmental Brain Research 1995, 88:37-52.
26. Carinato M.E., Walter B.E., Henry J.J. Xenopus laevis gelatinase B (Xmmp-9): development, regeneration, and wound healing. Developmental Dynamics 2000, 217:377-387.
27. Carulli D., Rhodes K.E., Brown D.J., Bonnert T.P., Pollack S.J., Oliver K., Strata P., Fawcett J.W. Composition of perineuronal nets in the adult rat cerebellum and the cellular origin of their components. Journal of Comparative Neurology 2006, 494:559-577.
28. Cauwe B., Opdenakker G. Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases. Critical Reviews in Biochemistry and Molecular Biology 2010, 45:351-423.
29. Chakraborti S., Mandal M., Das S., Mandal A., Chakraborti T. Regulation of matrix metalloproteinases: an overview. Molecular and Cellular Biochemistry 2003, 253:269-285.
30. Chandler S., Coates R., Gearing A., Lury J., Wells G., Bone E. Matrix metalloproteinases degrade myelin basic protein. Neuroscience Letters 1995, 201:223-226.
31. Chattopadhyay S., Shubayev V.I. MMP-9 controls Schwann cell proliferation and phenotypic remodeling via IGF-1 and ErbB receptor-mediated activation of MEK/ERK pathway. Glia 2009, 57:1316-1325.
32. Chaudhry K., Rogers R., Guo M., Lai Q., Goel G., Liebelt B., Ji X., Curry A., Carranza A., Jimenez D.F., Ding Y. Matrix metalloproteinase-9 (MMP-9) expression and extracellular signal-regulated kinase 1 and 2 (ERK1/2) activation in exercise-reduced neuronal apoptosis after stroke. Neuroscience Letters 2010, 474:109-114.
33. Chen B.S., Roche K.W. Regulation of NMDA receptors by phosphorylation. Neuropharmacology 2007, 53:362-368.
34. Chernoff E.A. Spinal cord regeneration: a phenomenon unique to urodeles?. International Journal of Developmental Biology 1996, 40:823-831.
35. Chernoff E.A., O'Hara C.M., Bauerle D., Bowling M. Matrix metalloproteinase production in regenerating axolotl spinal cord. Wound Repair and Regeneration 2000, 8:282-291.
36. Chernousov M.A., Yu W.M., Chen Z.L., Carey D.J., Strickland S. Regulation of Schwann cell function by the extracellular matrix. Glia 2008, 56:1498-1507.
37. Conant K., Lonskaya I., Szklarczyk A., Krall C., Steiner J., Maguire-Zeiss K., Lim S.T. Methamphetamine-associated cleavage of the synaptic adhesion molecule intercellular adhesion molecule-5. Journal of Neurochemistry 2011, 118:521-532.
38. Conant K., Wang Y., Szklarczyk A., Dudak A., Mattson M.P., Lim S.T. Matrix metalloproteinase-dependent shedding of intercellular adhesion molecule-5 occurs with long-term potentiation. Neuroscience 2010, 166:508-521.
39. Court F.A., Wrabetz L., Feltri M.L. Basal lamina: Schwann cells wrap to the rhythm of space-time. Current Opinion in Neurobiology 2006, 16:501-507.
40. Court F.A., Zambroni D., Pavoni E., Colombelli C., Baragli C., Figlia G., Sorokin L., Ching W., Salzer J.L., Wrabetz L., Feltri M.L. MMP2-9 cleavage of dystroglycan alters the size and molecular composition of Schwann cell domains. Journal of Neuroscience 2011, 31:12208-12217.
41. Crowe M.J., Bresnahan J.C., Shuman S.L., Masters J.N., Beattie M.S. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nature Medicine 1997, 3:73-76.
42. Cui Q., Yin Y., Benowitz L.I. The role of macrophages in optic nerve regeneration. Neuroscience 2009, 158:1039-1048.
43. Del Bigio M.R., Tchelingerian J.L., Jacque C.M. Expression of extracellular matrix degrading enzymes during migration of xenografted brain cells. Neuropathology and Applied Neurobiology 1999, 25:54-62.
44. Dityatev A., Schachner M. Extracellular matrix molecules and synaptic plasticity. Nature Reviews Neuroscience 2003, 4:456-468.
45. Duchossoy Y., Arnaud S., Feldblum S. Matrix metalloproteinases: potential therapeutic target in spinal cord injury. Clinical Chemistry and Laboratory Medicine 2001, 39:362-367.
46. Duchossoy Y., Horvat J.C., Stettler O. MMP-related gelatinase activity is strongly induced in scar tissue of injured adult spinal cord and forms pathways for ingrowing neurites. Molecular and Cellular Neurosciences 2001, 17:945-956.
47. Duong T.D., Erickson C.A. MMP-2 plays an essential role in producing epithelial-mesenchymal transformations in the avian embryo. Developmental Dynamics 2004, 229:42-53.
48. Dziembowska M., Milek J., Janusz A., Rejmak E., Romanowska E., Gorkiewicz T., Tiron A., Bramham C.R., Kaczmarek L. Activity-dependent local translation of matrix metalloproteinase-9. Journal of Neuroscience 2012, 32:14538-14547.
49. Ethell I.M., Ethell D.W. Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. Journal of Neuroscience Research 2007, 85:2813-2823.
50. Ethell I.M., Yamaguchi Y. Cell surface heparan sulfate proteoglycan syndecan-2 induces the maturation of dendritic spines in rat hippocampal neurons. Journal of Cell Biology 1999, 144:575-586.
51. Evers M.R., Salmen B., Bukalo O., Rollenhagen A., Bosl M.R., Morellini F., Bartsch U., Dityatev A., Schachner M. Impairment of L-type Ca2+ channel-dependent forms of hippocampal synaptic plasticity in mice deficient in the extracellular matrix glycoprotein tenascin-C. Journal of Neuroscience 2002, 22:7177-7194.
52. Faber-Elman A., Lavie V., Schvartz I., Shaltiel S., Schwartz M. Vitronectin overrides a negative effect of TNF-alpha on astrocyte migration. FASEB Journal 1995, 9:1605-1613.
53. Fang J., Shing Y., Wiederschain D., Yan L., Butterfield C., Jackson G., Harper J., Tamvakopoulos G., Moses M.A. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:3884-3889.
54. Fawcett J.W. Overcoming inhibition in the damaged spinal cord. Journal of Neurotrauma 2006, 23:371-383.
55. Fears C.Y., Gladson C.L., Woods A. Syndecan-2 is expressed in the microvasculature of gliomas and regulates angiogenic processes in microvascular endothelial cells. Journal of Biological Chemistry 2006, 281:14533-14536.
56. Ferguson T.A., Muir D. MMP-2 and MMP-9 increase the neurite-promoting potential of schwann cell basal laminae and are upregulated in degenerated nerve. Molecular and Cellular Neurosciences 2000, 16:157-167.
57. Filous A.R., Miller J.H., Coulson-Thomas Y.M., Horn K.P., Alilain W.J., Silver J. Immature astrocytes promote CNS axonal regeneration when combined with chondroitinase ABC. Developmental Neurobiology 2010, 70:826-841.
58. Fogel A.I., Akins M.R., Krupp A.J., Stagi M., Stein V., Biederer T. SynCAMs organize synapses through heterophilic adhesion. Journal of Neuroscience 2007, 27:12516-12530.
59. Forsyth P.A., Wong H., Laing T.D., Rewcastle N.B., Morris D.G., Muzik H., Leco K.J., Johnston R.N., Brasher P.M., Sutherland G., Edwards D.R. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. British Journal of Cancer 1999, 79:1828-1835.
60. Foscarin S., Ponchione D., Pajaj E., Leto K., Gawlak M., Wilczynski G.M., Rossi F., Carulli D. Experience-dependent plasticity and modulation of growth regulatory molecules at central synapses. PLoS One 2011, 6:e16666.
61. Fragkouli A., Papatheodoropoulos C., Georgopoulos S., Stamatakis A., Stylianopoulou F., Tsilibary E.C., Tzinia A.K. Enhanced neuronal plasticity and elevated endogenous sAPPalpha levels in mice over-expressing MMP9. Journal of Neurochemistry 2012, 121:239-251.
62. Fragkouli A., Tzinia A.K., Charalampopoulos I., Gravanis A., Tsilibary E.C. Matrix metalloproteinase-9 participates in NGF-induced alpha-secretase cleavage of amyloid-beta protein precursor in PC12 cells. Journal of Alzheimer's Disease 2011, 24:705-719.
63. Fredrich M., Illing R.B. MMP-2 is involved in synaptic remodeling after cochlear lesion. Neuroreport 2010, 21:324-327.
64. Frey U., Huang Y.Y., Kandel E.R. Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science 1993, 260:1661-1664.
65. Frolichsthal-Schoeller P., Vescovi A.L., Krekoski C.A., Murphy G., Edwards D.R., Forsyth P. Expression and modulation of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinases in human embryonic CNS stem cells. Neuroreport 1999, 10:345-351.
66. Fujita-Hamabe W., Tokuyama S. The involvement of cleavage of neural cell adhesion molecule in neuronal death under oxidative stress conditions in cultured cortical neurons. Biological and Pharmaceutical Bulletin 2012, 35:624-628.
67. Fukata Y., Itoh T.J., Kimura T., Menager C., Nishimura T., Shiromizu T., Watanabe H., Inagaki N., Iwamatsu A., Hotani H., Kaibuchi K. CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nature Cell Biology 2002, 4:583-591.
68. Furutani Y., Matsuno H., Kawasaki M., Sasaki T., Mori K., Yoshihara Y. Interaction between telencephalin and ERM family proteins mediates dendritic filopodia formation. Journal of Neuroscience 2007, 27:8866-8876.
69. Galis Z.S., Kranzhofer R., Fenton J.W., Libby P. Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology 1997, 17:483-489.
70. Gaudet A.D., Popovich P.G., Ramer M.S. Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. J Neuroinflammation 2011, 8:110.
71. Gawlak M., Gorkiewicz T., Gorlewicz A., Konopacki F.A., Kaczmarek L., Wilczynski G.M. High resolution in situ zymography reveals matrix metalloproteinase activity at glutamatergic synapses. Neuroscience 2009, 158:167-176.
72. Giambernardi T.A., Sakaguchi A.Y., Gluhak J., Pavlin D., Troyer D.A., Das G., Rodeck U., Klebe R.J. Neutrophil collagenase (MMP-8) is expressed during early development in neural crest cells as well as in adult melanoma cells. Matrix Biology 2001, 20:577-587.
73. Giannelli G., Falk-Marzillier J., Schiraldi O., Stetler-Stevenson W.G., Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 1997, 277:225-228.
74. Gijbels K., Masure S., Carton H., Opdenakker G. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. Journal of Neuroimmunology 1992, 41:29-34.
75. Giraudon P., Buart S., Bernard A., Thomasset N., Belin M.F. Extracellular matrix-remodeling metalloproteinases and infection of the central nervous system with retrovirus human T-lymphotropic virus type I (HTLV-I). Progress in Neurobiology 1996, 49:169-184.
76. Girolamo F., Virgintino D., Errede M., Capobianco C., Bernardini N., Bertossi M., Roncali L. Involvement of metalloprotease-2 in the development of human brain microvessels. Histochemistry and Cell Biology 2004, 122:261-270.
77. Gonthier B., Koncina E., Satkauskas S., Perraut M., Roussel G., Aunis D., Kapfhammer J.P., Bagnard D. A PKC-dependent recruitment of MMP-2 controls semaphorin-3A growth-promoting effect in cortical dendrites. PLoS One 2009, 4:e5099.
78. Gottschall P.E., Yu X., Bing B. Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture. Journal of Neuroscience Research 1995, 42:335-342.
79. Groc L., Choquet D., Stephenson F.A., Verrier D., Manzoni O.J., Chavis P. NMDA receptor surface trafficking and synaptic subunit composition are developmentally regulated by the extracellular matrix protein Reelin. Journal of Neuroscience 2007, 27:10165-10175.
80. Grosshans D.R., Clayton D.A., Coultrap S.J., Browning M.D. LTP leads to rapid surface expression of NMDA but not AMPA receptors in adult rat CA1. Nature Neuroscience 2002, 5:27-33.
81. Gu Z., Cui J., Brown S., Fridman R., Mobashery S., Strongin A.Y., Lipton S.A. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. Journal of Neuroscience 2005, 25:6401-6408.
82. Gu Z., Kaul M., Yan B., Kridel S.J., Cui J., Strongin A., Smith J.W., Liddington R.C., Lipton S.A. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 2002, 297:1186-1190.
83. Gueye Y., Ferhat L., Sbai O., Bianco J., Ould-Yahoui A., Bernard A., Charrat E., Chauvin J.P., Risso J.J., Feron F., Rivera S., Khrestchatisky M. Trafficking and secretion of matrix metalloproteinase-2 in olfactory ensheathing glial cells: A role in cell migration?. Glia 2011, 59:750-770.
84. Hehr C.L., Hocking J.C., McFarlane S. Matrix metalloproteinases are required for retinal ganglion cell axon guidance at select decision points. Development 2005, 132:3371-3379.
85. Higgins S., Wong S.H., Richner M., Rowe C.L., Newgreen D.F., Werther G.A., Russo V.C. Fibroblast growth factor 2 reactivates G1 checkpoint in SK-N-MC cells via regulation of p21, inhibitor of differentiation genes (Id1-3), and epithelium-mesenchyme transition-like events. Endocrinology 2009, 150:4044-4055.
86. Holtmaat A., Wilbrecht L., Knott G.W., Welker E., Svoboda K. Experience-dependent and cell-type-specific spine growth in the neocortex. Nature 2006, 441:979-983.
87. Horner P.J., Gage F.H. Regenerating the damaged central nervous system. Nature 2000, 407:963-970.
88. Hsu J.Y., McKeon R., Goussev S., Werb Z., Lee J.U., Trivedi A., Noble-Haeusslein L.J. Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury. Journal of Neuroscience 2006, 26:9841-9850.
89. Hu K., Yang J., Tanaka S., Gonias S.L., Mars W.M., Liu Y. Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression. Journal of Biological Chemistry 2006, 281:2120-2127.
90. Huang E.P. Synaptic plasticity: going through phases with LTP. Current Biology 1998, 8:R350-R352.
91. Huang S., Van Arsdall M., Tedjarati S., McCarty M., Wu W., Langley R., Fidler I.J. Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. Journal of the National Cancer Institute 2002, 94:1134-1142.
92. Huang Y.Y., Kandel E.R. Recruitment of long-lasting and protein kinase A-dependent long-term potentiation in the CA1 region of hippocampus requires repeated tetanization. Learning and Memory 1994, 1:74-82.
93. Huber K.M., Mauk M.D., Kelly P.T. Distinct LTP induction mechanisms: contribution of NMDA receptors and voltage-dependent calcium channels. Journal of Neurophysiology 1995, 73:270-279.
94. Huebner E.A., Strittmatter S.M. Axon regeneration in the peripheral and central nervous systems. Results and Problems in Cell Differentiation 2009, 48:339-351.
95. Hughes P.M., Wells G.M., Perry V.H., Brown M.C., Miller K.M. Comparison of matrix metalloproteinase expression during Wallerian degeneration in the central and peripheral nervous systems. Neuroscience 2002, 113:273-287.
96. Hwang J.J., Park M.H., Choi S.Y., Koh J.Y. Activation of the Trk signaling pathway by extracellular zinc. Role of metalloproteinases. Journal of Biological Chemistry 2005, 280:11995-12001.
97. Itoh Y., Takamura A., Ito N., Maru Y., Sato H., Suenaga N., Aoki T., Seiki M. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO Journal 2001, 20:4782-4793.
98. Ingraham C.A., Park G.C., Makarenkova H.P., Crossin K.L. Matrix metalloproteinase (MMP)-9 induced by Wnt signaling increases the proliferation and migration of embryonic neural stem cells at low O2 levels. Journal of Biological Chemistry 2011, 286:17649-17657.
99. Ingvarsen S., Porse A., Erpicum C., Maertens L., Jurgensen H.J., Madsen D.H., Melander M.C., Gardsvoll H., Hoyer-Hansen G., Noel A., Holmbeck K., Engelholm L.H., Behrendt N. Targeting a single function of the multifunctional matrix metalloprotease MT1-MMP. Impact on lymphangiogenesis. Journal of Biological Chemistry 2013.
100. Itoh T., Tanioka M., Yoshida H., Yoshioka T., Nishimoto H., Itohara S. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Research 1998, 58:1048-1051.
101. Jourquin J., Tremblay E., Decanis N., Charton G., Hanessian S., Chollet A.M., Le Diguardher T., Khrestchatisky M., Rivera S. Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. European Journal of Neuroscience 2003, 18:1507-1517.
102. Kalembeyi I., Inada H., Nishiura R., Imanaka-Yoshida K., Sakakura T., Yoshida T. Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1. International Journal of Cancer 2003, 105:53-60.
103. Kaliszewska A., Bijata M., Kaczmarek L., Kossut M. Experience-dependent plasticity of the barrel cortex in mice observed with 2-DG brain mapping and c-Fos: effects of MMP-9 KO. Cerebral Cortex 2011.
104. Kang S.S., Kook J.H., Hwang S., Park S.H., Nam S.C., Kim J.K. Inhibition of matrix metalloproteinase-9 attenuated neural progenitor cell migration after photothrombotic ischemia. Brain Research 2008, 1228:20-26.
105. Kanoh Y., Ohara T., Kanoh M., Akahoshi T. Serum matrix metalloproteinase-2 levels indicate blood-CSF barrier damage in patients with infectious meningitis. Inflammation 2008, 31:99-104.
106. Kapur A., Yeckel M.F., Gray R., Johnston D. L-type calcium channels are required for one form of hippocampal mossy fiber LTP. Journal of Neurophysiology 1998, 79:2181-2190.
107. Kato T., Kure T., Chang J.H., Gabison E.E., Itoh T., Itohara S., Azar D.T. Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Letters 2001, 508:187-190.
108. Kawano H., Kimura-Kuroda J., Komuta Y., Yoshioka N., Li H.P., Kawamura K., Li Y., Raisman G. Role of the lesion scar in the response to damage and repair of the central nervous system. Cell and Tissue Research 2012, 349:169-180.
109. Kawasaki Y., Xu Z.Z., Wang X., Park J.Y., Zhuang Z.Y., Tan P.H., Gao Y.J., Roy K., Corfas G., Lo E.H., Ji R.R. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nature Medicine 2008, 14:331-336.
110. Kim D.H., Lilliehook C., Roides B., Chen Z., Chang M., Mobashery S., Goldman S.A. Testosterone-induced matrix metalloproteinase activation is a checkpoint for neuronal addition to the adult songbird brain. Journal of Neuroscience 2008, 28:208-216.
111. Kim G.W., Kim H.J., Cho K.J., Kim H.W., Cho Y.J., Lee B.I. The role of MMP-9 in integrin-mediated hippocampal cell death after pilocarpine-induced status epilepticus. Neurobiology of Disease 2009, 36:169-180.
112. Kim Y., Remacle A.G., Chernov A.V., Liu H., Shubayev I., Lai C., Dolkas J., Shiryaev S.A., Golubkov V.S., Mizisin A.P., Strongin A.Y., Shubayev V.I. The MMP-9/TIMP-1 axis controls the status of differentiation and function of myelin-forming Schwann cells in nerve regeneration. PLoS One 2012, 7:e33664.
113. Klein T., Bischoff R. Physiology and pathophysiology of matrix metalloproteases. Amino Acids 2011, 41:271-290.
114. Konopacki F.A., Rylski M., Wilczek E., Amborska R., Detka D., Kaczmarek L., Wilczynski G.M. Synaptic localization of seizure-induced matrix metalloproteinase-9 mRNA. Neuroscience 2007, 150:31-39.
115. Kramar E.A., Lin B., Rex C.S., Gall C.M., Lynch G. Integrin-driven actin polymerization consolidates long-term potentiation. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:5579-5584.
116. Kryczka J., Stasiak M., Dziki L., Mik M., Dziki A., Cierniewski C. Matrix metalloproteinase-2 cleavage of the beta1 integrin ectodomain facilitates colon cancer cell motility. Journal of Biological Chemistry 2012, 287:36556-36566.
117. Lampert K., Machein U., Machein M.R., Conca W., Peter H.H., Volk B. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors. American Journal of Pathology 1998, 153:429-437.
118. Lariviere R.C., Julien J.P. Functions of intermediate filaments in neuronal development and disease. Journal of Neurobiology 2004, 58:131-148.
119. Larsen P.H., DaSilva A.G., Conant K., Yong V.W. Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and -12 null mice. Journal of Neuroscience 2006, 26:2207-2214.
120. Larsen P.H., Wells J.E., Stallcup W.B., Opdenakker G., Yong V.W. Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan. Journal of Neuroscience 2003, 23:11127-11135.
121. Lee S.R., Kim H.Y., Rogowska J., Zhao B.Q., Bhide P., Parent J.M., Lo E.H. Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke. Journal of Neuroscience 2006, 26:3491-3495.
122. Lee S.R., Tsuji K., Lo E.H. Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. Journal of Neuroscience 2004, 24:671-678.
123. Lehmann H.C., Kohne A., Bernal F., Jangouk P., Meyer Zu Horste G., Dehmel T., Hartung H.P., Previtali S.C., Kieseier B.C. Matrix metalloproteinase-2 is involved in myelination of dorsal root ganglia neurons. Glia 2009, 57:479-489.
124. Leppert D., Ford J., Stabler G., Grygar C., Lienert C., Huber S., Miller K.M., Hauser S.L., Kappos L. Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain 1998, 121(Pt 12):2327-2334.
125. Leppert D., Lindberg R.L., Kappos L., Leib S.L. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Research. Brain Research Reviews 2001, 36:249-257.
126. Levi E., Fridman R., Miao H.Q., Ma Y.S., Yayon A., Vlodavsky I. Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:7069-7074.
127. Lin K.T., Sloniowski S., Ethell D.W., Ethell I.M. Ephrin-B2-induced cleavage of EphB2 receptor is mediated by matrix metalloproteinases to trigger cell repulsion. Journal of Biological Chemistry 2008, 283:28969-28979.
128. Lin Y.C., Koleske A.J. Mechanisms of synapse and dendrite maintenance and their disruption in psychiatric and neurodegenerative disorders. Annual Review of Neuroscience 2010, 33:349-378.
129. Liu H., Shiryaev S.A., Chernov A.V., Kim Y., Shubayev I., Remacle A.G., Baranovskaya S., Golubkov V.S., Strongin A.Y., Shubayev V.I. Immunodominant fragments of myelin basic protein initiate T cell-dependent pain. Journal of Neuroinflammation 2012, 9:119.
130. Liu S., Fa M., Ninan I., Trinchese F., Dauer W., Arancio O. Alpha-synuclein involvement in hippocampal synaptic plasticity: role of NO, cGMP, cGK and CaMKII. European Journal of Neuroscience 2007, 25:3583-3596.
131. Lorenzl S., Albers D.S., Relkin N., Ngyuen T., Hilgenberg S.L., Chirichigno J., Cudkowicz M.E., Beal M.F. Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease. Neurochemistry International 2003, 43:191-196.
132. Lu L., Tonchev A.B., Kaplamadzhiev D.B., Boneva N.B., Mori Y., Sahara S., Ma D., Nakaya M.A., Kikuchi M., Yamashima T. Expression of matrix metalloproteinases in the neurogenic niche of the adult monkey hippocampus after ischemia. Hippocampus 2008, 18:1074-1084.
133. Madani R., Hulo S., Toni N., Madani H., Steimer T., Muller D., Vassalli J.D. Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice. EMBO Journal 1999, 18:3007-3012.
134. Mantuano E., Inoue G., Li X., Takahashi K., Gaultier A., Gonias S.L., Campana W.M. The hemopexin domain of matrix metalloproteinase-9 activates cell signaling and promotes migration of schwann cells by binding to low-density lipoprotein receptor-related protein. Journal of Neuroscience 2008, 28:11571-11582.
135. Martinez-Torres F.J., Wagner S., Haas J., Kehm R., Sellner J., Hacke W., Meyding-Lamade U. Increased presence of matrix metalloproteinases 2 and 9 in short- and long-term experimental herpes simplex virus encephalitis. Neuroscience Letters 2004, 368:274-278.
136. Martins-Oliveira A., Speciali J.G., Dach F., Marcaccini A.M., Goncalves F.M., Gerlach R.F., Tanus-Santos J.E. Different circulating metalloproteinases profiles in women with migraine with and without aura. Clinica Chimica Acta 2009, 408:60-64.
137. McCurley A.T., Callard G.V. Time course analysis of gene expression patterns in zebrafish eye during optic nerve regeneration. Journal of Experimental Neuroscience 2010, 2010:17-33.
138. McFarlane S., McNeill L., Holt C.E. FGF signaling and target recognition in the developing Xenopus visual system. Neuron 1995, 15:1017-1028.
139. Meighan S.E., Meighan P.C., Choudhury P., Davis C.J., Olson M.L., Zornes P.A., Wright J.W., Harding J.W. Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity. Journal of Neurochemistry 2006, 96:1227-1241.
140. Michaluk P., Kolodziej L., Mioduszewska B., Wilczynski G.M., Dzwonek J., Jaworski J., Gorecki D.C., Ottersen O.P., Kaczmarek L. Beta-dystroglycan as a target for MMP-9, in response to enhanced neuronal activity. Journal of Biological Chemistry 2007, 282:16036-16041.
141. Michaluk P., Mikasova L., Groc L., Frischknecht R., Choquet D., Kaczmarek L. Matrix metalloproteinase-9 controls NMDA receptor surface diffusion through integrin beta1 signaling. Journal of Neuroscience 2009, 29:6007-6012.
142. Michaluk P., Wawrzyniak M., Alot P., Szczot M., Wyrembek P., Mercik K., Medvedev N., Wilczek E., De Roo M., Zuschratter W., Muller D., Wilczynski G.M., Mozrzymas J.W., Stewart M.G., Kaczmarek L., Wlodarczyk J. Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology. Journal of Cell Science 2011, 124:3369-3380.
143. Mizoguchi, H., 2010. Alterations of Emotional and Cognitive Behaviors in Matrix Metalloproteinase-2 and -9-Deficient Mice.
144. Mizoguchi H., Yamada K., Nabeshima T. Matrix metalloproteinases contribute to neuronal dysfunction in animal models of drug dependence, Alzheimer's disease, and epilepsy. Biochemistry Research International 2011, 2011:681385.
145. Moissoglu K., Schwartz M.A. Integrin signalling in directed cell migration. Biologie Cellulaire 2006, 98:547-555.
146. Morrison C.J., Butler G.S., Bigg H.F., Roberts C.R., Soloway P.D., Overall C.M. Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway. Journal of Biological Chemistry 2001, 276:47402-47410.
147. Murase S., McKay R.D. Matrix metalloproteinase-9 regulates survival of neurons in newborn hippocampus. Journal of Biological Chemistry 2012, 287:12184-12194.
148. Murphy A.N., Unsworth E.J., Stetler-Stevenson W.G. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. Journal of Cellular Physiology 1993, 157:351-358.
149. Murphy G., Gavrilovic J. Proteolysis and cell migration: creating a path?. Current Opinion in Cell Biology 1999, 11:614-621.
150. Nagase H., Visse R., Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovascular Research 2006, 69:562-573.
151. Nagy V., Bozdagi O., Matynia A., Balcerzyk M., Okulski P., Dzwonek J., Costa R.M., Silva A.J., Kaczmarek L., Huntley G.W. Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. Journal of Neuroscience 2006, 26:1923-1934.
152. Nakamura H., Fujii Y., Inoki I., Sugimoto K., Tanzawa K., Matsuki H., Miura R., Yamaguchi Y., Okada Y. Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites. Journal of Biological Chemistry 2000, 275:38885-38890.
153. Nguyen M., Arkell J., Jackson C.J. Activated protein C directly activates human endothelial gelatinase A. Journal of Biological Chemistry 2000, 275:9095-9098.
154. Nguyen M., Arkell J., Jackson C.J. Human endothelial gelatinases and angiogenesis. International Journal of Biochemistry and Cell Biology 2001, 33:960-970.
155. Niebroj-Dobosz I., Janik P., Sokolowska B., Kwiecinski H. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. European Journal of Neurology 2010, 17:226-231.
156. Niedringhaus M., Chen X., Dzakpasu R., Conant K. MMPs and soluble ICAM-5 increase neuronal excitability within in vitro networks of hippocampal neurons. PLoS One 2012, 7:e42631.
157. Niethammer P., Delling M., Sytnyk V., Dityatev A., Fukami K., Schachner M. Cosignaling of NCAM via lipid rafts and the FGF receptor is required for neuritogenesis. Journal of Cell Biology 2002, 157:521-532.
158. Niikura Y., Abe K., Misawa M. Involvement of L-type Ca2+ channels in the induction of long-term potentiation in the basolateral amygdala-dentate gyrus pathway of anesthetized rats. Brain Research 2004, 1017:218-221.
159. Nishijima T., Piriz J., Duflot S., Fernandez A.M., Gaitan G., Gomez-Pinedo U., Verdugo J.M., Leroy F., Soya H., Nunez A., Torres-Aleman I. Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-I into the CNS. Neuron 2010, 67:834-846.
160. Noble L.J., Donovan F., Igarashi T., Goussev S., Werb Z. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. Journal of Neuroscience 2002, 22:7526-7535.
161. Ogata Y., Enghild J.J., Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. Journal of Biological Chemistry 1992, 267:3581-3584.
162. Ogier C., Bernard A., Chollet A.M.T., Hanessian L.E.D., Charton S., Khrestchatisky G., Rivera M.S. Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins. Glia 2006, 54:272-284.
163. Oh L.Y., Larsen P.H., Krekoski C.A., Edwards D.R., Donovan F., Werb Z., Yong V.W. Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. Journal of Neuroscience 1999, 19:8464-8475.
164. Okulski P., Jay T.M., Jaworski J., Duniec K., Dzwonek J., Konopacki F.A., Wilczynski G.M., Sanchez-Capelo A., Mallet J., Kaczmarek L. TIMP-1 abolishes MMP-9-dependent long-lasting long-term potentiation in the prefrontal cortex. Biological Psychiatry 2007, 62:359-362.
165. Overall C.M. Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites. Molecular Biotechnology 2002, 22:51-86.
166. Pastrana E., Moreno-Flores M.T., Gurzov E.N., Avila J., Wandosell F., Diaz-Nido J. Genes associated with adult axon regeneration promoted by olfactory ensheathing cells: a new role for matrix metalloproteinase 2. Journal of Neuroscience 2006, 26:5347-5359.
167. Penedo L.A., Oliveira-Silva P., Gonzalez E.M., Maciel R., Jurgilas P.B., Melibeu Ada C., Campello-Costa P., Serfaty C.A. Nutritional tryptophan restriction impairs plasticity of retinotectal axons during the critical period. Experimental Neurology 2009, 217:108-115.
168. Planas A.M., Sole S., Justicia C. Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia. Neurobiology of Disease 2001, 8:834-846.
169. Platt C.I., Krekoski C.A., Ward R.V., Edwards D.R., Gavrilovic J. Extracellular matrix and matrix metalloproteinases in sciatic nerve. Journal of Neuroscience Research 2003, 74:417-429.
170. Ponimaskin E., Dityateva G., Ruonala M.O., Fukata M., Fukata Y., Kobe F., Wouters F.S., Delling M., Bredt D.S., Schachner M., Dityatev A. Fibroblast growth factor-regulated palmitoylation of the neural cell adhesion molecule determines neuronal morphogenesis. Journal of Neuroscience 2008, 28:8897-8907.
171. Ridnour L.A., Windhausen A.N., Isenberg J.S., Yeung N., Thomas D.D., Vitek M.P., Roberts D.D., Wink D.A. Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:16898-16903.
172. Rivera S., Khrestchatisky M., Kaczmarek L., Rosenberg G.A., Jaworski D.M. Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?. Journal of Neuroscience 2010, 30:15337-15357.
173. Rocher C., Spedding M., Munoz C., Jay T.M. Acute stress-induced changes in hippocampal/prefrontal circuits in rats: effects of antidepressants. Cerebral Cortex 2004, 14:224-229.
174. Rosenberg G.A. Matrix metalloproteinases in brain injury. Journal of Neurotrauma 1995, 12:833-842.
175. Rosenberg G.A. Matrix metalloproteinases in neuroinflammation. Glia 2002, 39:279-291.
176. Rosenberg G.A. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurology 2009, 8:205-216.
177. Rosenberg G.A., Estrada E.Y., Dencoff J.E. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998, 29:2189-2195.
178. Rosenberg G.A., Kornfeld M., Estrada E., Kelley R.O., Liotta L.A., Stetler-Stevenson W.G. TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Research 1992, 576:203-207.
179. Ruoslahti E. RGD and other recognition sequences for integrins. Annual Review of Cell and Developmental Biology 1996, 12:697-715.
180. Sara Y., Biederer T., Atasoy D., Chubykin A., Mozhayeva M.G., Sudhof T.C., Kavalali E.T. Selective capability of SynCAM and neuroligin for functional synapse assembly. Journal of Neuroscience 2005, 25:260-270.
181. Saygili E., Schauerte P., Pekassa M., Rackauskas G., Schwinger R.H., Weis J., Weber C., Marx N., Rana O.R. Sympathetic neurons express and secrete MMP-2 and MT1-MMP to control nerve sprouting via pro-NGF conversion. Cellular and Molecular Neurobiology 2011, 31:17-25.
182. Sbai O., Ferhat L., Bernard A., Gueye Y., Ould-Yahoui A., Thiolloy S., Charrat E., Charton G., Tremblay E., Risso J.J., Chauvin J.P., Arsanto J.P., Rivera S., Khrestchatisky M. Vesicular trafficking and secretion of matrix metalloproteinases-2,-9 and tissue inhibitor of metalloproteinases-1 in neuronal cells. Molecular and Cellular Neurosciences 2008, 39:549-568.
183. Schram K., Ganguly R., No E.K., Fang X., Thong F.S., Sweeney G. Regulation of MT1-MMP and MMP-2 by leptin in cardiac fibroblasts involves Rho/ROCK-dependent actin cytoskeletal reorganization and leads to enhanced cell migration. Endocrinology 2011, 152:2037-2047.
184. Schulz P.E., Fitzgibbons J.C. Differing mechanisms of expression for short- and long-term potentiation. Journal of Neurophysiology 1997, 78:321-334.
185. Shichi K., Fujita-Hamabe W., Harada S., Mizoguchi H., Yamada K., Nabeshima T., Tokuyama S. Involvement of matrix metalloproteinase-mediated proteolysis of neural cell adhesion molecule in the development of cerebral ischemic neuronal damage. Journal of Pharmacology and Experimental Therapeutics 2011, 338:701-710.
186. Shubayev V.I., Myers R.R. Upregulation and interaction of TNFalpha and gelatinases A and B in painful peripheral nerve injury. Brain Research 2000, 855:83-89.
187. Shubayev V.I., Myers R.R. Endoneurial remodeling by TNFalph- and TNFalpha-releasing proteases. A spatial and temporal co-localization study in painful neuropathy. Journal of the Peripheral Nervous System 2002, 7:28-36.
188. Shubayev V.I., Myers R.R. Matrix metalloproteinase-9 promotes nerve growth factor-induced neurite elongation but not new sprout formation in vitro. Journal of Neuroscience Research 2004, 77:229-239.
189. Siebert H., Dippel N., Mader M., Weber F., Bruck W. Matrix metalloproteinase expression and inhibition after sciatic nerve axotomy. Journal of Neuropathology and Experimental Neurology 2001, 60:85-93.
190. Slevin M., Kumar P., Gaffney J., Kumar S., Krupinski J. Can angiogenesis be exploited to improve stroke outcome?. Mechanisms and therapeutic potential. Clinical Science (London) 2006, 111:171-183.
191. Smith G.M., Miller R.H. Immature type-1 astrocytes suppress glial scar formation, are motile and interact with blood vessels. Brain Research 1991, 543:111-122.
192. Sokolowska B., Jozwik A., Niebroj-Dobosz I., Janik P., Kwiecinski H. Evaluation of matrix metalloproteinases in serum of patients with amyotrophic lateral sclerosis with pattern recognition methods. Journal of Physiology and Pharmacology 2009, 60(Suppl. 5):117-120.
193. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. Journal of Pathology 2003, 200:448-464.
194. Steffensen B., Wallon U.M., Overall C.M. Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen. Journal of Biological Chemistry 1995, 270:11555-11566.
195. Sternlicht M.D., Werb Z. How matrix metalloproteinases regulate cell behavior. Annual Review of Cell and Developmental Biology 2001, 17:463-516.
196. Strekalova T., Sun M., Sibbe M., Evers M., Dityatev A., Gass P., Schachner M. Fibronectin domains of extracellular matrix molecule tenascin-C modulate hippocampal learning and synaptic plasticity. Molecular and Cellular Neurosciences 2002, 21:173-187.
197. Strongin A.Y., Collier I., Bannikov G., Marmer B.L., Grant G.A., Goldberg G.I. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. Journal of Biological Chemistry 1995, 270:5331-5338.
198. Szklarczyk A., Lapinska J., Rylski M., McKay R.D., Kaczmarek L. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. Journal of Neuroscience 2002, 22:920-930.
199. Takasu M.A., Dalva M.B., Zigmond R.E., Greenberg M.E. Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors. Science 2002, 295:491-495.
200. Tamada A., Yoshihara Y., Mori K. Dendrite-associated cell adhesion molecule, telencephalin, promotes neurite outgrowth in mouse embryo. Neuroscience Letters 1998, 240:163-166.
201. Tian L., Nyman H., Kilgannon P., Yoshihara Y., Mori K., Andersson L.C., Kaukinen S., Rauvala H., Gallatin W.M., Gahmberg C.G. Intercellular adhesion molecule-5 induces dendritic outgrowth by homophilic adhesion. Journal of Cell Biology 2000, 150:243-252.
202. Tian L., Stefanidakis M., Ning L., Van Lint P., Nyman-Huttunen H., Libert C., Itohara S., Mishina M., Rauvala H., Gahmberg C.G. Activation of NMDA receptors promotes dendritic spine development through MMP-mediated ICAM-5 cleavage. Journal of Cell Biology 2007, 178:687-700.
203. Tominaga M., Kamo A., Tengara S., Ogawa H., Takamori K. In vitro model for penetration of sensory nerve fibres on a Matrigel basement membrane: implications for possible application to intractable pruritus. British Journal of Dermatology 2009, 161:1028-1037.
204. Triolo D., Dina G., Lorenzetti I., Malaguti M., Morana P., Del Carro U., Comi G., Messing A., Quattrini A., Previtali S.C. Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage. Journal of Cell Science 2006, 119:3981-3993.
205. Turk B.E., Huang L.L., Piro E.T., Cantley L.C. Determination of protease cleavage site motifs using mixture-based oriented peptide libraries. Nature Biotechnology 2001, 19:661-667.
206. Uhm J.H., Dooley N.P., Oh L.Y., Yong V.W. Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix. Glia 1998, 22:53-63.
207. Ulrich R., Gerhauser I., Seeliger F., Baumgartner W., Alldinger S. Matrix metalloproteinases and their inhibitors in the developing mouse brain and spinal cord: a reverse transcription quantitative polymerase chain reaction study. Developmental Neuroscience 2005, 27:408-418.
208. Vaillant C., Didier-Bazes M., Hutter A., Belin M.F., Thomasset N. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum. Journal of Neuroscience 1999, 19:4994-5004.
209. Vaillant C., Meissirel C., Mutin M., Belin M.F., Lund L.R., Thomasset N. MMP-9 deficiency affects axonal outgrowth, migration, and apoptosis in the developing cerebellum. Molecular and Cellular Neurosciences 2003, 24:395-408.
210. Van den Steen P.E., Dubois B., Nelissen I., Rudd P.M., Dwek R.A., Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Critical Reviews in Biochemistry and Molecular Biology 2002, 37:375-536.
211. Van Wart H.E., Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:5578-5582.
212. Veeravalli K.K., Dasari V.R., Tsung A.J., Dinh D.H., Gujrati M., Fassett D., Rao J.S. Human umbilical cord blood stem cells upregulate matrix metalloproteinase-2 in rats after spinal cord injury. Neurobiology of Disease 2009, 36:200-212.
213. Virgintino D., Girolamo F., Errede M., Capobianco C., Robertson D., Stallcup W.B., Perris R., Roncali L. An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis. Angiogenesis 2007, 10:35-45.
214. Volianskis A., Jensen M.S. Transient and sustained types of long-term potentiation in the CA1 area of the rat hippocampus. Journal of Physiology 2003, 550:459-492.
215. Wang L., Zhang Z.G., Zhang R.L., Gregg S.R., Hozeska-Solgot A., LeTourneau Y., Wang Y., Chopp M. Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. Journal of Neuroscience 2006, 26:5996-6003.
216. Wang S.H., Liao X.M., Liu D., Hu J., Yin Y.Y., Wang J.Z., Zhu L.Q. NGF promotes long-term memory formation by activating poly(ADP-ribose)polymerase-1. Neuropharmacology 2010, 63:1085-1092.
217. Wang X.B., Bozdagi O., Nikitczuk J.S., Zhai Z.W., Zhou Q., Huntley G.W. Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinately. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:19520-19525.
218. Wiera G., Wojtowicz T., Lebida K., Piotrowska A., Drulis-Fajdasz D., Gomulkiewicz A., Gendosz D., Podhorska-Okolow M., Capogna M., Wilczynski G., Dziegiel P., Kaczmarek L., Mozrzymas J.W. Long term potentiation affects intracellular metalloproteinases activity in the mossy fiber - CA3 pathway. Molecular and Cellular Neurosciences 2012, 50:147-159.
219. Wilczynski G.M., Konopacki F.A., Wilczek E., Lasiecka Z., Gorlewicz A., Michaluk P., Wawrzyniak M., Malinowska M., Okulski P., Kolodziej L.R., Konopka W., Duniec K., Mioduszewska B., Nikolaev E., Walczak A., Owczarek D., Gorecki D.C., Zuschratter W., Ottersen O.P., Kaczmarek L. Important role of matrix metalloproteinase 9 in epileptogenesis. Journal of Cell Biology 2008, 180:1021-1035.
220. Wojcik-Stanaszek L., Gregor A., Zalewska T. Regulation of neurogenesis by extracellular matrix and integrins. Acta Neurobiologiae Experimentalis (Wars) 2011, 71:103-112.
221. Wojcik L., Sawicka A., Rivera S., Zalewska T. Neurogenesis in gerbil hippocampus following brain ischemia: focus on the involvement of metalloproteinases. Acta Neurobiologiae Experimentalis (Wars) 2009, 69:52-61.
222. Wu B., Crampton S.P., Hughes C.C. Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 2007, 26:227-239.
223. Wyszynski M., Lin J., Rao A., Nigh E., Beggs A.H., Craig A.M., Sheng M. Competitive binding of alpha-actinin and calmodulin to the NMDA receptor. Nature 1997, 385:439-442.
224. Yang Y., Estrada E.Y., Thompson J.F., Liu W., Rosenberg G.A. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. Journal of Cerebral Blood Flow and Metabolism 2007, 27:697-709.
225. Yiu G., He Z. Glial inhibition of CNS axon regeneration. Nature Reviews Neuroscience 2006, 7:617-627.
226. Yong V.W. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nature Reviews Neuroscience 2005, 6:931-944.
227. Yong V.W., Agrawal S.M., Stirling D.P. Targeting MMPs in acute and chronic neurological conditions. Neurotherapeutics 2007, 4:580-589.
228. Zhang J.W., Deb S., Gottschall P.E. Regional and differential expression of gelatinases in rat brain after systemic kainic acid or bicuculline administration. European Journal of Neuroscience 1998, 10:3358-3368.
229. Zhao B.Q., Wang S., Kim H.Y., Storrie H., Rosen B.R., Mooney D.J., Wang X., Lo E.H. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nature Medicine 2006, 12:441-445.
230. Zuo J., Ferguson T.A., Hernandez Y.J., Stetler-Stevenson W.G., Muir D. Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan. Journal of Neuroscience 1998, 18:5203-5211.